Amputation rate and mortality in elderly patients with Critical Limb Ischemia not suitable for revascularization

Aging Clinical and Experimental Research

Volumn 24, Issue SUPPL.3, 2012, Pages 24-27

  Martini, Romeo ^a   Andreozzi, Giuseppe Maria ^a   Deri, Alessandra ^a   Cordova, Rosamaria ^a   Zulian, Paolo ^a   Scarpazza, Ornella ^a   Nalin, Fabiana ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Conservative treatment; Critical limb ischemia

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CLOPIDOGREL; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; PROSTAGLANDIN E1; TICLOPIDINE;

AGE; AGED; ANALGESIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; FEMALE; FUNCTIONAL STATUS; GANGRENE; GENDER; GERIATRIC PATIENT; HUMAN; HYPERBARIC OXYGEN; HYPERTENSION; LEG AMPUTATION; LEG PAIN; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; SKIN INJURY; SMOKING; SPINAL CORD STIMULATION; VEIN BLOOD FLOW; WOUND CARE;

AGED; AGED, 80 AND OVER; AMPUTATION; COHORT STUDIES; FEMALE; HUMANS; ISCHEMIA; LEG; LIMB SALVAGE; MALE; RETROSPECTIVE STUDIES;

EID: 84872699184     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR. Harris KA, Fowkes FGR, on behalf of the TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33: S1-70.
2. Bosiers M, Peeters P, Elst FV et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study. Eur J Vasc Endovasc Surg 2005; 29: 613-9.
3. Zeller T, Rastan A, Schwarzwalder U et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses with a new generation device: six-month results from a single center experience. J Endovasc Ther 2004; 11: 676-85.
4. Alonso-Coello P, Bellmunt S, McGorrian C et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl 2): e669S-90S.
5. UK Severe Limb Ischaemia Study Group: Treatment of limb threatening ischaemia with intravenous Iloprost: A randomised double-blind placebo controlled study. Eur J Vasc Surg 1991; 5: 511-6.
6. Norgren L, Alwmark A, Angqvist KA et al. A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study. Eur J Vasc Surg 1990; 4: 463-7.
7. Altstaedt HO, Berzewski B, Breddin HK et al. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 573-8.
8. Diehm C, Hübsch-Müller C, Stammler F. Intravenöse Prostaglandin E1-Therapie bei Patienten mit peripherer arterieller Verschlusskrankheit (pAVK) im Stadium III - eine doppelblinde, placebokontrollierte Studie. In Heidrich H, Böhme H, Rogatti W (Eds) Prostaglandin E1 - Wirkungen und therapeutische Wirksamkeit. Springer Verlag: Berlin/Heidelberg/New York, 1988: 133-43.
9. Stiegler H, Diehm C, Grom E et al. Placebo controlled, doubleblind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease. Vasa Suppl 1992; 35: 164-6.
10. Balzer K, Bechara G, Bisler H. Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost. Int Angiol 1991; 10: 229-32.
11. Ruffolo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev 2010; (1):CD006544.
12. Nikol S, Baumgartner I, Van Belle E et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 2008; 16: 972-8.
13. Belch J, Hiatt WR, Baumgartner I et al; on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011; 377: 1929-37.
14. Amann B, Lüdemann C, Rückert R et al. Design and rationale of a randomized, double-blind, placebo controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI). Vasa 2008; 37: 319-25.